Hangzhou Tigermed Consulting

About

Hangzhou Tigermed Consulting (SHE:300347) — investor relations, events, news, and company updates on 6ix.

Financials

Revenue
CN¥6.83 B
Market Cap
CN¥47.61 B
P/E Ratio
53.17
EPS
1.04
Dividend Yield
0.22%

Community Chat

Ask AI